The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

Eli Lilly’s Zepbound drug holds potential to dominate the global obesity market due to its superior efficacy and strategic ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Check out all our end-of-year content—the latest Heart Sounds podcast reviews the reporters’ own favorite stories for 2024, ...

In the quest for optimal health, particularly hormonal balance, many individuals find themselves overwhelmed by the myriad of ...

The singer reflected on being ‘so broken and dark’ a year ago.

Novartis’ AveXis unit has said European regulators have approved its Zolgensma (onasemnogene ... But Zolgensma is also the world’s most expensive drug, costing $2.1 million for the single ...

Drugmakers to raise US prices on over 250 medicines starting Jan. 1 Healthcare & Pharmaceuticalscategory · 2:30 PM UTC · Updated ago U.S. dollar banknotes and medicines are seen in this ...